Literature DB >> 19999953

Critical factors influencing the establishment, maintenance and sustainability of population-based cancer control programs.

Edward J Trapido1, Josep Maria Borras, Robert Burton, Massoud Samiei, Mark Elwood.   

Abstract

Developing and maintaining a comprehensive cancer control program are two distinct entities. Key issues related to building and sustaining cancer control programs include how to integrate initiatives and efforts across multiple constituencies addressing components of the implementation of cancer control and non-communicable disease programs, the processes used in different resource settings to achieve effective drug budgeting, health technology assessment and health economics, and how countries can support public and societal engagement. There are promising examples in both resource-rich and resource-challenged countries of constituencies that have developed programs which can contribute to comprehensive cancer control. Some take advantage of newer technology and information services, while others are more people and patient focused. Critical issues and factors for establishing and maintaining population-based comprehensive cancer control programs are identified and reviewed.

Entities:  

Mesh:

Year:  2009        PMID: 19999953     DOI: 10.1177/030089160909500506

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  1 in total

Review 1.  Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.

Authors:  Silvina Frech; Catherine A Muha; Lisa M Stevens; Edward L Trimble; Roxanne Brew; Doug Puricelli Perin; Silvana Luciani; Alejandro Mohar; Marion Piñeros; Tatiana Vidaurre; Douglas R Morgan; Ernest T Hawk; Kathleen M Schmeler; Lewis E Foxhall; Cristina Rabadan-Diehl; Denise Duran; Melissa Rendler-Garcia; Eduardo L Cazap; Luiz Santini; Walter Zoss; Lucia B Delgado; Paul C Pearlman; Leslie Given; Karin Hohman; Melissa S Lopez; Brenda Kostelecky
Journal:  J Glob Oncol       Date:  2018-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.